End Of Line for Cilengitide in Glioblastoma

Cilengitide fails to improve overall survival for newly diagnosed glioblastoma patients...

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.